API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/ferinject-approved-by-health-canada-for-the-treatment-of-iron-deficiency-anemia-in-adult-and-pediatric-patients-and-iron-deficiency-in-adult-patients-with-heart-failure-302092736.html
https://endpts.com/daiichi-sankyo-scores-first-nod-for-iv-iron-replacement-drug-in-patients-with-heart-failure/
https://www.indianpharmapost.com/news/emcure-pharmaceuticals-to-launch-the750-mg-injectable-variant-of-ferric-carboxymaltose-14143
https://www.pharmtech.com/view/ferinject-approved-in-china-for-the-treatment-of-iron-deficiency-in-adult-patients
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-ferric-carboxymaltose-inj-45184.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-ferric-carboxymaltose-injection-1649312342.pdf
https://www.prnewswire.com/news-releases/injectafer-ferric-carboxymaltose-injection-receives-fda-approval-for-single-dose-option-for-the-treatment-of-adult-patients-with-iron-deficiency-anemia-301285079.html
https://www.reuters.com/article/us-vifor-heart-failure/vifors-ferinject-misses-target-in-heart-failure-trial-idUSKCN26F0RK
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-injectafer-203565-ferric-carboxymaltose-for-injection-750-mg15-ml-1558417336.pdf
https://www.fiercepharma.com/marketing/daiichi-sankyo-partners-crohn-s-colitis-foundation-to-draws-attention-to-iron-deficits
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Intravenous_iron-containing_medicinal_products/human_referral_000343.jsp&mid=WC0b01ac05805c516f
http://www.pharmatimes.com/news/pharma_firms_fall_foul_of_abpi_code_1188921